SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-10T02:44:17.442682+00:00","dedupe_key":"signal_enriched:news_delta:d1bccec4e3bd3164","evidence_event_ids":["evt_85a1f4694858"],"signal_type":"news_headline_delta","source":"news_rss","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE84aU9tdk8wblNEc0RvUnFCMFdXYXBteVhxaW84SXRNUWVUUGtlYXZjRzNxRnlKSWFLTEVNN3FtdUpYMk9IcU42YmdfTDhHVE5xYmJtNUVlZlpNTk9YZ0E4?oc=5","as_of":"2026-04-10T02:44:17.442682+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE84aU9tdk8wblNEc0RvUnFCMFdXYXBteVhxaW84SXRNUWVUUGtlYXZjRzNxRnlKSWFLTEVNN3FtdUpYMk9IcU42YmdfTDhHVE5xYmJtNUVlZlpNTk9YZ0E4?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_5c3e0fd9f3964d17","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T02:45:33.075775+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE84aU9tdk8wblNEc0RvUnFCMFdXYXBteVhxaW84SXRNUWVUUGtlYXZjRzNxRnlKSWFLTEVNN3FtdUpYMk9IcU42YmdfTDhHVE5xYmJtNUVlZlpNTk9YZ0E4?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"nature.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE84aU9tdk8wblNEc0RvUnFCMFdXYXBteVhxaW84SXRNUWVUUGtlYXZjRzNxRnlKSWFLTEVNN3FtdUpYMk9IcU42YmdfTDhHVE5xYmJtNUVlZlpNTk9YZ0E4?oc=5","source_event_id":"evt_85a1f4694858","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"a1711897faa14820","published_at":"2026-04-09T15:59:52+00:00","publisher_domain":"nature.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.55,"dates_mentioned":[],"entities":[{"asset_class":"media","name":"Nature","relevance":"high","symbol":"","type":"publisher"},{"asset_class":"healthcare_technology","name":"CAR-T cell therapy","relevance":"high","symbol":"","type":"medical_technology"},{"asset_class":"human","name":"One woman (patient)","relevance":"high","symbol":"","type":"individual"},{"asset_class":"disease","name":"Three autoimmune diseases (ultra-rare trio)","relevance":"high","symbol":"","type":"medical_condition_group"}],"event_type":"research","information_gaps":["The specific autoimmune disease names are not present in the provided text.","The CAR-T target/construct, treatment protocol, and whether this is a single-patient case report vs. a study cohort are not provided.","Timing details (when remission occurred) are not included in the provided content.","Outcome measures (e.g., biomarkers, duration of remission, follow-up length) are not included.","Safety/toxicity details (e.g., cytokine release syndrome, neurotoxicity) are not included.","The exact Nature article title/date and trial/registry identifiers are not provided in the supplied material."],"key_facts":["The report is published by Nature (nature.com).","The headline describes a single woman with three autoimmune diseases described as ultra-rare.","The headline claims CAR-T therapy \u201cvanquishes\u201d the disease trio and results in remission/recovery.","The provided source summary and cross-publication snippets describe the patient as moving from bedridden/severe to \u201cperfectly fine\u201d/well-being (wording varies by outlet)."],"numeric_claims":[],"primary_claim":"A CAR-T cell therapy led a woman with three ultra-rare autoimmune diseases into remission/recovery.","relevance_score":0.62,"sentiment":"positive","source_quality":"high","summary":"Nature reports a case in which CAR-T cell therapy produced remission in a woman suffering from an ultra-rare trio of autoimmune diseases. The headline frames the outcome as a near \u201cimmune reset,\u201d moving the patient from severe illness to well-being.","topics":["CAR-T","cell therapy","autoimmune disease","ultra-rare diseases","remission","immune reset","case report"]},"source":"Nature","source_domain":"nature.com","source_url":"https://www.nature.com","summary":"One woman, three autoimmune diseases: CAR-T therapy vanquishes ultra-rare disease trio Nature Woman with three deadly diseases has \u2018remarkable\u2019 recovery after cell therapy The Guardian Woman With 3 Autoimmune Diseases Enters Remission After Immune 'Reset' ScienceAlert Scientists Are Finally Unlocking a Cancer Treatment\u2019s Full Potential The Atlantic CAR T-cell therapy takes woman from bedridden to 'perfectly fine' New Scientist","title":"One woman, three autoimmune diseases: CAR-T therapy vanquishes ultra-rare disease trio - Nature","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 13128 in events